GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (XSAT:EQL) » Definitions » Price-to-Operating-Cash-Flow

EQL Pharma AB (XSAT:EQL) Price-to-Operating-Cash-Flow : 67.29 (As of May. 01, 2024)


View and export this data going back to 2013. Start your Free Trial

What is EQL Pharma AB Price-to-Operating-Cash-Flow?

As of today (2024-05-01), EQL Pharma AB's share price is kr43.40. EQL Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.65. Hence, EQL Pharma AB's Price-to-Operating-Cash-Flow Ratio for today is 67.29.

The historical rank and industry rank for EQL Pharma AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

XSAT:EQL' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.47   Med: 39.33   Max: 316.25
Current: 67.28

During the past 11 years, EQL Pharma AB's highest Price-to-Operating-Cash-Flow Ratio was 316.25. The lowest was 8.47. And the median was 39.33.

XSAT:EQL's Price-to-Operating-Cash-Flow is ranked worse than
90.69% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.63 vs XSAT:EQL: 67.28

EQL Pharma AB's Cash Flow from Operations per share for the three months ended in Dec. 2023 was kr0.08. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.65.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of EQL Pharma AB was -41.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 59.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 152.90% per year.

During the past 11 years, EQL Pharma AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 565.80% per year. The lowest was 53.30% per year. And the median was 80.70% per year.


EQL Pharma AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for EQL Pharma AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Price-to-Operating-Cash-Flow Chart

EQL Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.07 58.26 16.99 21.91 40.00

EQL Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.69 40.00 117.39 47.93 51.78

Competitive Comparison of EQL Pharma AB's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Price-to-Operating-Cash-Flow falls into.



EQL Pharma AB Price-to-Operating-Cash-Flow Calculation

EQL Pharma AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=43.40/0.645
=67.29

EQL Pharma AB's Share Price of today is kr43.40.
EQL Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

EQL Pharma AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (XSAT:EQL) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (XSAT:EQL) Headlines

From GuruFocus